LyophilisedCJC-IPA
CJC-1295 + Ipamorelin Combination
Bulk≥99.5% Purity
Pre-combined CJC-1295 + Ipamorelin for synergistic dual-pathway growth hormone stimulation.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
This combination activates two complementary GH-releasing pathways: CJC-1295 stimulates GHRH receptors while Ipamorelin activates ghrelin/GHS receptors. The dual stimulation produces synergistic GH pulse amplitude exceeding either peptide alone, without cortisol or prolactin elevation from the selective Ipamorelin component.
Clinical Benefits
- Synergistic GH release via dual receptor activation
- GHRH + GHRP combined mechanism
- Enhanced GH pulse amplitude and frequency
- Convenient pre-combined formulation
Specifications
ComponentsCJC-1295 + Ipamorelin
MechanismGHRH + GHS dual pathway
Purity≥99.5% (each component)
Storage & Handling
- Store at -20°C
- Reconstituted: 2–8°C
- Protect from light
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.